KEVIN GAREY to Secondary Prevention
This is a "connection" page, showing publications KEVIN GAREY has written about Secondary Prevention.
Connection Strength
0.110
-
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011 Dec; 66(12):2850-5.
Score: 0.086
-
Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis. 2013 Apr; 56(7):1059-60.
Score: 0.023